G Protein-coupled Receptors: Computer-aided Ligand Discovery and Computational Structural Analyses in the 2010s

Overview

Journal In Silico Pharmacol

Date 2014 Dec 16

PMID 25505664

Authors

Stefano Costanzi

Affiliations

Soon will be listed here.

Abstract

G protein-coupled receptors, or GPCRs, are a large superfamily of proteins found on the plasma membrane of cells. They are involved in most physiological and pathophysiological functions and constitute the target of the majority of marketed drugs. Although these receptors have been historically elusive to attempts of structural determination, GPCR crystallography is now in full blossom, opening the way to structure-based drug discovery and enabling homology modeling. This thematic issue of the journal In Silico Pharmacology, which illustrates how the expanding body of structural knowledge is fostering complex computational analyses of the structure-function relationships of the receptors and their interactions with their ligands, stems from the 31st Camerino-Cyprus-Noordwijkerhout Symposium held in Italy, in May 2013, at the University of Camerino. Specifically, it originates from a session of the symposium entitled "Structure-Based Discovery of Ligands of G Protein-Coupled Receptors: Finally a Reality", and features a mix of research articles and reviews on the application of computational modeling to the analysis of the structure of GPCRs and the interactions of the receptors with their ligands.

References

Costanzi S, Siegel J, Tikhonova I, Jacobson K . Rhodopsin and the others: a historical perspective on structural studies of G protein-coupled receptors. Curr Pharm Des. 2009; 15(35):3994-4002. PMC: 2801150. DOI: 10.2174/138161209789824795. View

Steyaert J, Kobilka B . Nanobody stabilization of G protein-coupled receptor conformational states. Curr Opin Struct Biol. 2011; 21(4):567-72. PMC: 3166880. DOI: 10.1016/j.sbi.2011.06.011. View

Costanzi S, Wang K . The GPCR crystallography boom: providing an invaluable source of structural information and expanding the scope of homology modeling. Adv Exp Med Biol. 2013; 796:3-13. DOI: 10.1007/978-94-007-7423-0_1. View

Kruse A, Manglik A, Kobilka B, Weis W . Applications of molecular replacement to G protein-coupled receptors. Acta Crystallogr D Biol Crystallogr. 2013; 69(Pt 11):2287-92. PMC: 3817703. DOI: 10.1107/S090744491301322X. View

Mason J, Bortolato A, Congreve M, Marshall F . New insights from structural biology into the druggability of G protein-coupled receptors. Trends Pharmacol Sci. 2012; 33(5):249-60. DOI: 10.1016/j.tips.2012.02.005. View

Reiter E, Ahn S, Shukla A, Lefkowitz R . Molecular mechanism of β-arrestin-biased agonism at seven-transmembrane receptors. Annu Rev Pharmacol Toxicol. 2011; 52:179-97. PMC: 3628752. DOI: 10.1146/annurev.pharmtox.010909.105800. View

Sheftel S, Muratore K, Black M, Costanzi S . Graph analysis of β2 adrenergic receptor structures: a "social network" of GPCR residues. In Silico Pharmacol. 2014; 1:16. PMC: 4230308. DOI: 10.1186/2193-9616-1-16. View

Floris M, Sabbadin D, Ciancetta A, Medda R, Cuzzolin A, Moro S . Implementing the "Best Template Searching" tool into Adenosiland platform. In Silico Pharmacol. 2014; 1:25. PMC: 4230649. DOI: 10.1186/2193-9616-1-25. View

Lane J, Chubukov P, Liu W, Canals M, Cherezov V, Abagyan R . Structure-based ligand discovery targeting orthosteric and allosteric pockets of dopamine receptors. Mol Pharmacol. 2013; 84(6):794-807. PMC: 3834142. DOI: 10.1124/mol.113.088054. View

10.

Lefkowitz R . A brief history of G-protein coupled receptors (Nobel Lecture). Angew Chem Int Ed Engl. 2013; 52(25):6366-78. DOI: 10.1002/anie.201301924. View

11.

Martin N, Whalen E, Zamah M, Pierce K, Lefkowitz R . PKA-mediated phosphorylation of the beta1-adrenergic receptor promotes Gs/Gi switching. Cell Signal. 2004; 16(12):1397-403. DOI: 10.1016/j.cellsig.2004.05.002. View

12.

Congreve M, Marshall F . The impact of GPCR structures on pharmacology and structure-based drug design. Br J Pharmacol. 2009; 159(5):986-96. PMC: 2839258. DOI: 10.1111/j.1476-5381.2009.00476.x. View

13.

Cherezov V, Rosenbaum D, Hanson M, Rasmussen S, Thian F, Kobilka T . High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. Science. 2007; 318(5854):1258-65. PMC: 2583103. DOI: 10.1126/science.1150577. View

14.

Stevens R, Cherezov V, Katritch V, Abagyan R, Kuhn P, Rosen H . The GPCR Network: a large-scale collaboration to determine human GPCR structure and function. Nat Rev Drug Discov. 2012; 12(1):25-34. PMC: 3723354. DOI: 10.1038/nrd3859. View

15.

Kobilka B . The structural basis of G-protein-coupled receptor signaling (Nobel Lecture). Angew Chem Int Ed Engl. 2013; 52(25):6380-8. PMC: 4031317. DOI: 10.1002/anie.201302116. View

16.

Venkatakrishnan A, Deupi X, Lebon G, Tate C, Schertler G, Babu M . Molecular signatures of G-protein-coupled receptors. Nature. 2013; 494(7436):185-94. DOI: 10.1038/nature11896. View

17.

Jacobson K . Crystal structures of the A adenosine receptor and their use in medicinal chemistry. In Silico Pharmacol. 2014; 1:22. PMC: 3956660. DOI: 10.1186/2193-9616-1-22. View

18.

Jacobson K, Costanzi S . New insights for drug design from the X-ray crystallographic structures of G-protein-coupled receptors. Mol Pharmacol. 2012; 82(3):361-71. PMC: 3422707. DOI: 10.1124/mol.112.079335. View

19.

Pierce K, Premont R, Lefkowitz R . Seven-transmembrane receptors. Nat Rev Mol Cell Biol. 2002; 3(9):639-50. DOI: 10.1038/nrm908. View

20.

Rasmussen S, Choi H, Rosenbaum D, Kobilka T, Thian F, Edwards P . Crystal structure of the human beta2 adrenergic G-protein-coupled receptor. Nature. 2007; 450(7168):383-7. DOI: 10.1038/nature06325. View